OP23 Guselkumab induction restores intestinal immune homeostasis and promotes epithelial repair in moderately to severely active Ulcerative Colitis
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Crohn's and Colitis"
DOI: 10.1093/ecco-jcc/jjad212.0023
Abstract: Selective inhibition of interleukin-23 (IL-23) through antagonism of the IL-23p19 subunit has demonstrated clinical efficacy in inflammatory bowel disease, but the mechanism of action (MoA) has not been fully defined. Here we provide a detailed… read more here.
Keywords: moderately severely; active ulcerative; cell; severely active ... See more keywords
Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials.
Sign Up to like & getrecommendations! Published in 2022 at "Inflammatory bowel diseases"
DOI: 10.1093/ibd/izac135
Abstract: BACKGROUND Fecal microbiota transplantation (FMT) has been investigated as a treatment option for patients with inflammatory bowel disease with controversial results.We sought to perform a systematic review and meta-analysis to evaluate the benefit of FMT… read more here.
Keywords: fmt; remission; active ulcerative; ulcerative colitis ... See more keywords
Fecal microbiota transplantation for patients with active ulcerative colitis: A cost‐effectiveness analysis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Gastroenterology and Hepatology"
DOI: 10.1111/jgh.16015
Abstract: Growing studies have demonstrated clinical benefits of fecal microbiota transplantation (FMT) therapy (administered by colonoscopy, enema, or both) for active ulcerative colitis (UC). This study aimed to evaluate the cost‐effectiveness of standard treatment with and… read more here.
Keywords: microbiota transplantation; fecal microbiota; active ulcerative; ulcerative colitis ... See more keywords
Bilateral pulmonary embolism and pulmonary infarctions in active ulcerative colitis
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-249428
Abstract: Crohn’s disease and ulcerative colitis are inflammatory bowel diseases (IBDs) and they primarily involve the intestines and confer an increased risk of thromboembolism (TE). Here we report a case of a young man with active… read more here.
Keywords: pulmonary infarctions; active ulcerative; colitis; pulmonary embolism ... See more keywords
Clinical Evaluation of Upadacitinib in the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis (UC): Patient Selection and Reported Outcomes
Sign Up to like & getrecommendations! Published in 2023 at "Clinical and Experimental Gastroenterology"
DOI: 10.2147/ceg.s367086
Abstract: Abstract This review addresses appropriate patient selection for upadacitinib, a Janus kinase inhibitor approved by the FDA and EMA for treatment of moderately to severely active ulcerative colitis (UC). Janus kinase molecules can contribute to the… read more here.
Keywords: patient selection; active ulcerative; severely active; ulcerative colitis ... See more keywords
Therapeutic Potential of Etrasimod in the Management of Moderately-to-Severely Active Ulcerative Colitis: Evidence to Date
Sign Up to like & getrecommendations! Published in 2024 at "Clinical and Experimental Gastroenterology"
DOI: 10.2147/ceg.s391706
Abstract: Abstract Etrasimod is a sphingosine 1 phosphate (S1P) receptor modulator approved for the treatment of moderate to severely active ulcerative colitis (UC). Etrasimod selectively activates S1P1,4,5 receptors with no detectable activity on S1P2,3. The ELEVATE… read more here.
Keywords: active ulcerative; therapeutic potential; etrasimod; ulcerative colitis ... See more keywords
The efficacy of curcumin/Qing Dai combination in children with active ulcerative colitis: a multicenter retrospective cohort study
Sign Up to like & getrecommendations! Published in 2024 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2024.1342656
Abstract: Background Curcumin and Qing Dai (QD) are herbal extracts that recently showed efficacy in treating inflammatory bowel disease (IBD). Since 2016, a combination of curcumin with QD (CurQD) has been employed in our center for… read more here.
Keywords: active ulcerative; curcumin; ulcerative colitis; curcumin qing ... See more keywords
Herbal Medicines for the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2024 at "Nutrients"
DOI: 10.3390/nu16070934
Abstract: Herbal medicines are used by patients with IBD despite limited evidence. We present a systematic review and meta-analysis of randomized controlled trials (RCTs) investigating treatment with herbal medicines in active ulcerative colitis (UC). A search… read more here.
Keywords: meta analysis; active ulcerative; systematic review; review meta ... See more keywords
Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice
Sign Up to like & getrecommendations! Published in 2017 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v23.i16.2995
Abstract: AIM To examine treatment decisions of gastroenterologists regarding the choice of prescribing 5-aminosalycilates (5ASA) with corticosteroids (CS) versus corticosteroids alone for patients with active ulcerative colitis (UC). METHODS A cross-sectional questionnaire exploring physicians’ attitude toward… read more here.
Keywords: combination; alone patients; corticosteroids alone; gastroenterology ... See more keywords